Is GGSM or JNJ a better dividend investment in 2026?

GGSM currently yields 250000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: GGSM offers higher current income.

What is the dividend yield difference between GGSM and JNJ?

GGSM has a forward dividend yield of 250000.00% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 249997.87 percentage points.

Home › Compare › GGSM vs JNJ

GGSM vs JNJ: Dividend Comparison 2026

GGSM yields 250000.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GGSM wins by $4.567699004441311e+30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GGSM

● Live price

250000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.567699004441311e+30M

Annual income

$4,564,107,688,187,857,300,000,000,000,000,000,000.00

Full GGSM calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — GGSM vs JNJ

📍 GGSM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GGSM	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GGSM + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GGSM pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GGSM

Annual income on $10K today (after 15% tax)

$21,250,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,879,491,534,959,678,500,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, GGSM beats the other by $3,879,491,534,959,678,500,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GGSM + JNJ for your $10,000?

GGSM: 50%JNJ: 50%

100% JNJ50/50100% GGSM

Portfolio after 10yr

$2.2838495022206556e+30M

Annual income

$2,282,053,844,093,928,700,000,000,000,000,000,000.00/yr

Blended yield

99.92%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GGSM

No analyst data

Altman Z

0.0

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GGSM buys

JNJ buys

Politician	Chamber	Ticker	Type	Amount	Date
Thomas R. Carper	🏛 Senate	$GGSM	▼ Sell	$1,001 - $15,000	2021-02-12
Thomas R. Carper	🏛 Senate	$GGSM	▼ Sell	$1,001 - $15,000	2021-02-12

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGGSMJNJ

Forward yield	250000.00% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$4.567699004441311e+30M	$30.3K ✓
Annual income after 10y	$4,564,107,688,187,857,300,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$4.567463897060879e+30M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GGSM vs JNJ ($10,000, DRIP)

Year	GGSM Portfolio	GGSM Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$25,010,700	$25,000,000.00	$10,592	$272.30	+$25.00M → GGSM
2	$58,462,976,402	$58,436,214,953.27	$11,289	$357.73	+$58462.97M → GGSM
3	$127,722,124,784,416	$127,659,569,399,665.92	$12,123	$472.89	+$127722124.77M → GGSM
4	$260,784,910,907,288,130	$260,648,248,233,768,800.00	$13,141	$629.86	+$260784910907.27M → GGSM
5	$497,657,939,618,196,950,000	$497,378,899,763,526,240,000.00	$14,408	$846.81	+$497657939618196.94M → GGSM
6	$887,590,576,640,622,200,000,000	$887,058,082,645,230,600,000,000.00	$16,021	$1,151.60	+$887590576640622208.00M → GGSM
7	$1,479,547,418,610,237,200,000,000,000	$1,478,597,696,693,231,600,000,000,000.00	$18,122	$1,588.22	+$1.4795474186102372e+21M → GGSM
8	$2,305,052,548,351,757,200,000,000,000,000	$2,303,469,432,613,844,500,000,000,000,000.00	$20,930	$2,228.20	+$2.3050525483517572e+24M → GGSM
9	$3,356,370,330,330,650,300,000,000,000,000,000	$3,353,903,924,103,914,000,000,000,000,000,000.00	$24,792	$3,191.91	+$3.3563703303306504e+27M → GGSM
10	$4,567,699,004,441,311,000,000,000,000,000,000,000	$4,564,107,688,187,857,300,000,000,000,000,000,000.00	$30,274	$4,689.40	+$4.567699004441311e+30M → GGSM

GGSM vs JNJ: Complete Analysis 2026

GGSM — Stock

Gold and GemStone Mining Inc. focuses on the acquisition, exploration, and development of gold and silver properties in North and South America. It has a collaboration agreement with Ridgeback Mining (Sierra Leone) Limited regarding a joint venture on three diamond and gold properties in Sierra Leone. The company holds mining claims in British Columbia, Canada and Sinaloa, Mexico for gold and rare earth metals. It also has 100% interest in the Gringo Viejo Project that consists of 3,202 hectares and is located on the best gold zone, Mexico. The company was formerly known as Global GSM Solutions, Inc. and changed its name to Gold and GemStone Mining Inc. in April 2012. Gold and GemStone Mining Inc. was founded in 2008 and is based in Irving, Texas.

Full GGSM Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this GGSM vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GGSM vs SCHD GGSM vs JEPI GGSM vs O GGSM vs KO GGSM vs MAIN GGSM vs ABBV GGSM vs MRK GGSM vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.